A phase Ib study of oral panobinostat (LBH589) administered with 5-azacitidine (5-Aza) in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or acute myeloid leukemia (AML)
Abstract only
Saved in:
Published in | Journal of clinical oncology Vol. 28; no. 15_suppl; p. TPS282 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
20.05.2010
|
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract only |
---|---|
ISSN: | 0732-183X 1527-7755 |
DOI: | 10.1200/jco.2010.28.15_suppl.tps282 |